Nicot Christophe相关文献与解析，生知库 | 链接生命科学的每一步

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer.

Jab1 调节 HRR mRNA 稳定性，从而调节三阴性乳腺癌中 PARP 抑制剂的敏感性

Peng Xin, Wang Yingying, Yu Zixiang, Huang Shengfan, Zhang Shaolu, Zhong Zhenxing, Wang Yongzhe, Liu Shanshan, Wang Kailin, Nicot Christophe, Claret Francois X, Kong Dexin

肿瘤

乳腺癌

发表日期：2025

文献求助收藏

The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7.

HTLV-I 癌蛋白 Tax 可使肿瘤抑制因子 FBXW7 失活

期刊:Journal of Virology

影响因子:3.8

doi:10.1128/jvi.00405-24

Bellon Marcia, Yeh Chien-Hung, Bai Xue Tao, Nicot Christophe

肿瘤

发表日期：2024

文献求助收藏

HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation

HTLV-1 的“税收拉锯战”：细胞衰老和死亡还是细胞转化

期刊:Pathogens

影响因子:3.3

doi:10.3390/pathogens13010087

Bellon, Marcia; Nicot, Christophe

Targeting Pim kinases in hematological cancers: molecular and clinical review

靶向Pim激酶治疗血液肿瘤：分子和临床综述

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-023-01721-1

Bellon, Marcia; Nicot, Christophe

circRNAs shed light on cancer diagnosis and treatment

环状RNA为癌症诊断和治疗提供新的思路

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-022-01580-2

PRMT7: a survive-or-die switch in cancer stem cells

PRMT7：癌症干细胞中的生存或死亡开关

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-022-01602-z

Clinical significance of FBXW7 loss of function in human cancers

FBXW7功能丧失在人类癌症中的临床意义

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-022-01548-2

Fan, Jingyi; Bellon, Marcia; Ju, Mingyi; Zhao, Lin; Wei, Minjie; Fu, Liwu; Nicot, Christophe

Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression

更正：NCAPG通过上调LGALS1表达促进非小细胞肺癌细胞的肿瘤发生和进展。

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-022-01689-4

Sun, Huanhuan; Zhang, Hong; Yan, Yan; Li, Yushi; Che, Gang; Zhou, Cuiling; Nicot, Christophe; Ma, Haiqing

CircRNA aptamer targets IGF2BP2 to overcome acquired BETi resistance

环状RNA适体靶向IGF2BP2以克服获得性β-内酰胺酶抑制剂耐药性

Clinical approaches to overcome PARP inhibitor resistance

克服PARP抑制剂耐药性的临床方法

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer.

Jab1 调节 HRR mRNA 稳定性，从而调节三阴性乳腺癌中 PARP 抑制剂的敏感性

The HTLV-I oncoprotein Tax inactivates the tumor suppressor FBXW7.

HTLV-I 癌蛋白 Tax 可使肿瘤抑制因子 FBXW7 失活

HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation

HTLV-1 的“税收拉锯战”：细胞衰老和死亡还是细胞转化

Targeting Pim kinases in hematological cancers: molecular and clinical review

靶向Pim激酶治疗血液肿瘤：分子和临床综述

circRNAs shed light on cancer diagnosis and treatment

环状RNA为癌症诊断和治疗提供新的思路

PRMT7: a survive-or-die switch in cancer stem cells

PRMT7：癌症干细胞中的生存或死亡开关

Clinical significance of FBXW7 loss of function in human cancers

FBXW7功能丧失在人类癌症中的临床意义

Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression

更正：NCAPG通过上调LGALS1表达促进非小细胞肺癌细胞的肿瘤发生和进展。